InnoPhage Revenue
Biotechnology Research • 
Portugal • 1-10 Employees
$
InnoPhage revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at InnoPhage
Pilar Baylina
Owner
Company overview
| Headquarters | Portugal |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Employees | 1-10 |
About InnoPhage
InnoPhage is a spin-off company from the Catholic University - College of Biotechnology in Porto. The business targets the production of bacteriophages for controlling bacterial infections. Innophage is a knowledge-based biotechnology company devoted to exploit new technological platforms in the Health sector with special focus in the environment based detection of resistant bacteria. The company is based in a strong R&D through international cooperation and business networking.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Funding Data
InnoPhage has never raised funding before.
Canada
United States
South Africa
United Kingdom
SpainFrequently asked questions
InnoPhage is located in PT.
InnoPhage generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
InnoPhage has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
InnoPhage has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
